PLN 50.9
(5.17%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 309.18 Million PLN | -0.82% |
2022 | 311.75 Million PLN | 19.43% |
2021 | 261.03 Million PLN | 294.7% |
2020 | 66.13 Million PLN | 52.99% |
2019 | 43.22 Million PLN | 84.79% |
2018 | 23.39 Million PLN | 120.74% |
2017 | 10.59 Million PLN | -68.28% |
2016 | 33.4 Million PLN | 81.95% |
2015 | 18.36 Million PLN | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 326.68 Million PLN | 4.83% |
2024 Q1 | 311.64 Million PLN | 0.8% |
2023 Q3 | 317.24 Million PLN | 4.73% |
2023 Q4 | 309.18 Million PLN | -2.54% |
2023 Q1 | 310.8 Million PLN | -0.3% |
2023 Q2 | 302.92 Million PLN | -2.54% |
2023 FY | 309.18 Million PLN | -0.82% |
2022 Q4 | 311.75 Million PLN | 17.6% |
2022 Q2 | 251.42 Million PLN | -4.06% |
2022 FY | 311.75 Million PLN | 19.43% |
2022 Q1 | 262.05 Million PLN | 0.39% |
2022 Q3 | 265.1 Million PLN | 5.44% |
2021 Q4 | 261.03 Million PLN | 15.91% |
2021 FY | 261.03 Million PLN | 294.7% |
2021 Q3 | 225.21 Million PLN | 7.75% |
2021 Q2 | 209.01 Million PLN | -3.64% |
2021 Q1 | 216.91 Million PLN | 227.99% |
2020 Q3 | 66.76 Million PLN | 9.58% |
2020 Q1 | 54.07 Million PLN | 25.08% |
2020 Q4 | 66.13 Million PLN | -0.94% |
2020 Q2 | 60.92 Million PLN | 12.67% |
2020 FY | 66.13 Million PLN | 52.99% |
2019 Q3 | 18.3 Thousand PLN | 0.0% |
2019 FY | 43.22 Million PLN | 84.79% |
2019 Q4 | 43.22 Million PLN | 236048.25% |
2019 Q1 | 40.8 Million PLN | 0.0% |
2018 Q1 | - PLN | 0.0% |
2018 FY | 23.39 Million PLN | 120.74% |
2017 FY | 10.59 Million PLN | -68.28% |
2016 FY | 33.4 Million PLN | 81.95% |
2015 FY | 18.36 Million PLN | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
BioMaxima S.A. | 19.93 Million PLN | -1450.747% |
Scope Fluidics S.A. | 16.81 Million PLN | -1738.872% |
Voxel S.A. | 233.62 Million PLN | -32.343% |